Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroid-stimulating hormone receptor

被引:52
作者
Kleinau, Gunnar
Claus, Maren
Jaeschke, Holger
Mueller, Sandra
Neumann, Susanne
Paschke, Ralf
Krause, Gerd
机构
[1] Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany
[2] Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany
[3] NIDDK, NIH, Bethesda, MD 20814 USA
关键词
D O I
10.1074/jbc.M606176200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of alanine mutations in extracellular loop two (ECL2) of the thyroid-stimulating hormone receptor (TSHR) were found to increase or decrease basal activity when compared with the wild type receptor. K565A was identified as a mutant with decreased basal activity, and strongly impaired hormone induced signaling activity. To gain insights into how ECL2 mutants affect basal activity, we focused on constitutively activating pathogenic mutant 1568V in ECL2, which exhibits elevated basal activity. Because our molecular model suggests that Ile-568 is embedded in an environment of hydrophobic residues provided by transmembrane helix bundle, we tested mutants in this region to identify potential interaction partner(s) for Ile-568. Indeed, the double mutant 1568V/1640L (ECL2/TMH6) suppresses the increased basal activity exhibited by 1568V alone. We suggest a spatial and functional relationship between ECL2 and TMH6 in which side chain interaction between Ile-568 and Ile-640 constrains the receptor in a conformation with low basal activity. Although the single mutant 1640L exhibits basal activity lower than wild type, its differently branched and bulkier side chain complements the reduced side chain bulk in 1568V, restoring wild type basal activity to the double mutant. This scenario is confirmed by the reciprocal double mutant 1640V/I568L. The combination of basally increased activity of 1640V and basally decreased activity of mutant 1568L also restores basal activity of wild type TSHR. These and other mutant phenotypes reported here support a dynamic interface between TMH6 and ECL2. Disruption of this critical interface for signaling by introduction of mutations in TSHR can either increase or decrease basal activity.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 49 条
[11]   Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling [J].
Costanzi, S ;
Mamedova, L ;
Gao, ZG ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) :5393-5404
[12]   A defined epitope on the human choriogonadotropin alpha-subunit interacts with the second extracellular loop of the transmembrane domain of the lutropin/choriogonadotropin receptor [J].
Couture, L ;
Remy, JJ ;
Rabesona, H ;
Troalen, F ;
PajotAugy, E ;
Bozon, V ;
Haertle, T ;
Bidart, JM ;
Salesse, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 241 (02) :627-632
[13]   Thyrotropin receptor-associated diseases: from adenomata to Graves disease [J].
Davies, TF ;
Ando, T ;
Lin, RY ;
Tomer, Y ;
Latif, R .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :1972-1983
[14]   Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry [J].
Dragic, T ;
Trkola, A ;
Lin, SW ;
Nagashima, KA ;
Kajumo, F ;
Zhao, L ;
Olson, WC ;
Wu, LJ ;
Mackay, CR ;
Allaway, GP ;
Sakmar, TP ;
Moore, JP ;
Maddon, PJ .
JOURNAL OF VIROLOGY, 1998, 72 (01) :279-285
[15]   The luteinizing hormone receptor [J].
Dufau, ML .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :461-496
[16]   Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene [J].
Duprez, L ;
Hermans, J ;
VanSande, J ;
Dumont, JE ;
Vassart, G ;
Parma, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :306-308
[17]   Structure of human follicle-stimulating hormone in complex with its receptor [J].
Fan, QR ;
Hendrickson, WA .
NATURE, 2005, 433 (7023) :269-277
[18]   Somatic mutations in the thyrotropin receptor gene and not in the G(s)alpha protein gene in 31 toxic thyroid nodules [J].
Fuhrer, D ;
Holzapfel, HP ;
Wonerow, P ;
Scherbaum, WA ;
Paschke, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3885-3891
[19]   Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop [J].
Herold, CL ;
Qi, AD ;
Harden, TK ;
Nicholas, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11456-11464
[20]   A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR) [J].
Jäschke, H ;
Neumann, S ;
Moore, S ;
Thomas, CJ ;
Colson, AO ;
Costanzi, S ;
Kleinau, G ;
Jiang, JK ;
Paschke, R ;
Raaka, BM ;
Krause, G ;
Gershengorn, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :9841-9844